Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416272 · ClinicalTrials.gov registry record · NA
Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01416272: Clinical Trial NA study, sponsored by Bausch & Lomb Incorporated.
NCT01416272 is a NA study that was terminated before completion, run by Bausch & Lomb Incorporated. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01416272, a NA study, was terminated before completion, sponsored by Bausch & Lomb Incorporated.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.
Primary Outcome
Symptoms and complaints measured on an analog scale
Interventions
- DEVICE KeraSoft IC Soft Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-02 |
| Phase | NA |
Why NCT01416272 stopped before completion
NCT01416272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which KeraSoft IC Soft Contact Lenses is the first listed.
NCT01416272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01416272 about?
NCT01416272 is a clinical study titled "Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses". The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.
What is the current status of trial NCT01416272?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2011-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01416272?
The interventions under investigation include: KeraSoft IC Soft Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT01416272?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01416272's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia